Literature DB >> 24451368

Myostatin induces insulin resistance via Casitas B-lineage lymphoma b (Cblb)-mediated degradation of insulin receptor substrate 1 (IRS1) protein in response to high calorie diet intake.

Sabeera Bonala1, Sudarsanareddy Lokireddy, Craig McFarlane, Sreekanth Patnam, Mridula Sharma, Ravi Kambadur.   

Abstract

To date a plethora of evidence has clearly demonstrated that continued high calorie intake leads to insulin resistance and type-2 diabetes with or without obesity. However, the necessary signals that initiate insulin resistance during high calorie intake remain largely unknown. Our results here show that in response to a regimen of high fat or high glucose diets, Mstn levels were induced in muscle and liver of mice. High glucose- or fat-mediated induction of Mstn was controlled at the level of transcription, as highly conserved carbohydrate response and sterol-responsive (E-box) elements were present in the Mstn promoter and were revealed to be critical for ChREBP (carbohydrate-responsive element-binding protein) or SREBP1c (sterol regulatory element-binding protein 1c) regulation of Mstn expression. Further molecular analysis suggested that the increased Mstn levels (due to high glucose or fatty acid loading) resulted in increased expression of Cblb in a Smad3-dependent manner. Casitas B-lineage lymphoma b (Cblb) is an ubiquitin E3 ligase that has been shown to specifically degrade insulin receptor substrate 1 (IRS1) protein. Consistent with this, our results revealed that elevated Mstn levels specifically up-regulated Cblb, resulting in enhanced ubiquitin proteasome-mediated degradation of IRS1. In addition, over expression or knock down of Cblb had a major impact on IRS1 and pAkt levels in the presence or absence of insulin. Collectively, these observations strongly suggest that increased glucose levels and high fat diet, both, result in increased circulatory Mstn levels. The increased Mstn in turn is a potent inducer of insulin resistance by degrading IRS1 protein via the E3 ligase, Cblb, in a Smad3-dependent manner.

Entities:  

Keywords:  Cblb; Diabetes; High Fat Diet; High Glucose; IRS1; Insulin Resistance; Myostatin; Signaling; Skeletal Muscle; Skeletal Muscle Metabolism

Mesh:

Substances:

Year:  2014        PMID: 24451368      PMCID: PMC3953277          DOI: 10.1074/jbc.M113.529925

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  69 in total

1.  Peroxisome proliferator-activated receptor β/δ induces myogenesis by modulating myostatin activity.

Authors:  Sabeera Bonala; Sudarsanareddy Lokireddy; Harikumar Arigela; Serena Teng; Walter Wahli; Mridula Sharma; Craig McFarlane; Ravi Kambadur
Journal:  J Biol Chem       Date:  2012-02-23       Impact factor: 5.157

2.  Effect of dietary protein content on weight gain, energy expenditure, and body composition during overeating: a randomized controlled trial.

Authors:  George A Bray; Steven R Smith; Lilian de Jonge; Hui Xie; Jennifer Rood; Corby K Martin; Marlene Most; Courtney Brock; Susan Mancuso; Leanne M Redman
Journal:  JAMA       Date:  2012-01-04       Impact factor: 56.272

3.  Involvement of visfatin in palmitate-induced upregulation of inflammatory cytokines in hepatocytes.

Authors:  Yong Jun Choi; Sung E Choi; Eun Suk Ha; Yup Kang; Seung Jin Han; Dae Jung Kim; Kwan Woo Lee; Hae Jin Kim
Journal:  Metabolism       Date:  2011-06-12       Impact factor: 8.694

4.  Myostatin promotes the wasting of human myoblast cultures through promoting ubiquitin-proteasome pathway-mediated loss of sarcomeric proteins.

Authors:  Sudarsanareddy Lokireddy; Vincent Mouly; Gillian Butler-Browne; Peter D Gluckman; Mridula Sharma; Ravi Kambadur; Craig McFarlane
Journal:  Am J Physiol Cell Physiol       Date:  2011-09-07       Impact factor: 4.249

5.  Identification and functional analysis of CBLB mutations in type 1 diabetes.

Authors:  Norihide Yokoi; Yuuka Fujiwara; He-Yao Wang; Mai Kitao; Chihiro Hayashi; Tomohiro Someya; Masao Kanamori; Yutaka Oiso; Naoko Tajima; Yuichiro Yamada; Yutaka Seino; Hiroshi Ikegami; Susumu Seino
Journal:  Biochem Biophys Res Commun       Date:  2008-01-15       Impact factor: 3.575

6.  ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver.

Authors:  Pierre-Damien Denechaud; Pascale Bossard; Jean-Marc A Lobaccaro; Lesley Millatt; Bart Staels; Jean Girard; Catherine Postic
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

7.  High glucose-mediated alterations of mechanisms important in myogenesis of mouse C2C12 myoblasts.

Authors:  K Grzelkowska-Kowalczyk; W Wieteska-Skrzeczyńska; K Grabiec; J Tokarska
Journal:  Cell Biol Int       Date:  2012-11-14       Impact factor: 3.612

8.  Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice.

Authors:  David L Allen; Allison S Cleary; Kristin J Speaker; Sarah F Lindsay; Jill Uyenishi; Jason M Reed; Molly C Madden; Ryan S Mehan
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-03-11       Impact factor: 4.310

9.  Pid1 induces insulin resistance in both human and mouse skeletal muscle during obesity.

Authors:  Sabeera Bonala; Craig McFarlane; Jackie Ang; Radiance Lim; Marcus Lee; Hillary Chua; Sudarsanareddy Lokireddy; Patnam Sreekanth; Melvin Khee Shing Leow; Khoo Chin Meng; Tai E Shyong; Yung Seng Lee; Peter D Gluckman; Mridula Sharma; Ravi Kambadur
Journal:  Mol Endocrinol       Date:  2013-08-08

10.  Plasma and muscle myostatin in relation to type 2 diabetes.

Authors:  Claus Brandt; Anders R Nielsen; Christian P Fischer; Jakob Hansen; Bente K Pedersen; Peter Plomgaard
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

View more
  15 in total

Review 1.  Chronic Kidney Disease-Induced Insulin Resistance: Current State of the Field.

Authors:  Natasha Dave; Jiao Wu; Sandhya Thomas
Journal:  Curr Diab Rep       Date:  2018-06-08       Impact factor: 4.810

2.  SMAD3 negatively regulates serum irisin and skeletal muscle FNDC5 and peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α) during exercise.

Authors:  Joseph P Tiano; Danielle A Springer; Sushil G Rane
Journal:  J Biol Chem       Date:  2015-02-03       Impact factor: 5.157

3.  Does myostatin induce insulin resistance?

Authors:  Buel D Rodgers
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

4.  AgRP Neurons Control Systemic Insulin Sensitivity via Myostatin Expression in Brown Adipose Tissue.

Authors:  Sophie M Steculorum; Johan Ruud; Ismene Karakasilioti; Heiko Backes; Linda Engström Ruud; Katharina Timper; Martin E Hess; Eva Tsaousidou; Jan Mauer; Merly C Vogt; Lars Paeger; Stephan Bremser; Andreas C Klein; Donald A Morgan; Peter Frommolt; Paul T Brinkkötter; Philipp Hammerschmidt; Thomas Benzing; Kamal Rahmouni; F Thomas Wunderlich; Peter Kloppenburg; Jens C Brüning
Journal:  Cell       Date:  2016-03-24       Impact factor: 41.582

5.  Myostatin serum levels in children with type 1 diabetes mellitus.

Authors:  Alexandra Efthymiadou; Ioannis-Anargyros Vasilakis; Aristeidis Giannakopoulos; Dionisios Chrysis
Journal:  Hormones (Athens)       Date:  2021-09-06       Impact factor: 2.885

Review 6.  Skeletal muscle as a therapeutic target for delaying type 1 diabetic complications.

Authors:  Samantha K Coleman; Irena A Rebalka; Donna M D'Souza; Thomas J Hawke
Journal:  World J Diabetes       Date:  2015-12-10

7.  Statin myalgia is not associated with reduced muscle strength, mass or protein turnover in older male volunteers, but is allied with a slowing of time to peak power output, insulin resistance and differential muscle mRNA expression.

Authors:  Joanne E Mallinson; Kanagaraj Marimuthu; Andrew Murton; Anna Selby; Kenneth Smith; Dumitru Constantin-Teodosiu; Michael J Rennie; Paul L Greenhaff
Journal:  J Physiol       Date:  2015-01-26       Impact factor: 5.182

8.  Relationship between grip strength and newly diagnosed nonalcoholic fatty liver disease in a large-scale adult population.

Authors:  Ge Meng; Hongmei Wu; Liyun Fang; Chunlei Li; Fei Yu; Qing Zhang; Li Liu; Huanmin Du; Hongbin Shi; Yang Xia; Xiaoyan Guo; Xing Liu; Xue Bao; Qian Su; Yeqing Gu; Huijun Yang; Yuntang Wu; Zhong Sun; Kaijun Niu
Journal:  Sci Rep       Date:  2016-09-12       Impact factor: 4.379

9.  Loss-of-function myostatin mutation increases insulin sensitivity and browning of white fat in Meishan pigs.

Authors:  Chunbo Cai; Lili Qian; Shengwang Jiang; Youde Sun; Qingqing Wang; Dezun Ma; Gaojun Xiao; Biao Li; Shanshan Xie; Ting Gao; Yaoxing Chen; Jie Liu; Xiaorong An; Wentao Cui; Kui Li
Journal:  Oncotarget       Date:  2017-05-23

10.  Unraveling the molecular heterogeneity in type 2 diabetes: a potential subtype discovery followed by metabolic modeling.

Authors:  Maryam Khoshnejat; Kaveh Kavousi; Ali Mohammad Banaei-Moghaddam; Ali Akbar Moosavi-Movahedi
Journal:  BMC Med Genomics       Date:  2020-08-24       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.